ICARES MedicusROCO:6612 +1.13%84 Operating Margin % is 7.48% as of Dec. 2025, which is 66% below its 10-year median of 22.21. GuruFocus rates ROCO:6612 with a GF Score™ of 84/100 and a GF Value™ of NT$188.59 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 816 Medical Devices & Instruments companies, ICARES Medicus ranks better than 69.24% on this metric.
ICARES Medicus Inc operating margin has been in a 5-year decline. The average rate of decline per year is -12.5%.
The historical rank and industry rank for ICARES Medicus's Operating Margin % or its related term are showing as below:
ROCO:6612'
s Operating Margin % Range Over the Past 10 Years
Min: 11.35 Med: 22.21 Max: 28.16
Current: 11.36
ROCO:6612's Operating Margin % is ranked better than 69.24% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.4
vs ROCO:6612: 11.36
ICARES Medicus's 5-Year Average Operating Margin % Growth Rate was -12.50% per year.
ICARES Medicus (ROCO:6612) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
ICARES Medicus Operating Margin % Related Terms
ICARES Medicus Operating Margin % Historical Data
* Premium members only.
The historical data trend for ICARES Medicus's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6612 vs ISRG, BDX, MDLN: Operating Margin % Comparison
For the Medical Instruments & Supplies subindustry, ICARES Medicus's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICARES Medicus Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICARES Medicus's Operating Margin % distribution charts can be found below:
* The bar in red indicates where ICARES Medicus's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
ICARES Medicus's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICARES Medicus (ROCO:6612) has a Operating Margin % of 7.48% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on ICARES Medicus and its competitors. This is 66% below median its historical median of 22.21. Over the past decade, ICARES Medicus' Operating Margin % has ranged from 11.35 to 28.16. According to the industry distribution chart, ICARES Medicus ranks #251 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 30.8%.
Is ICARES Medicus' Operating Margin % too high?
ICARES Medicus' current Operating Margin % of 7.48% is 66% below median its 10-year median of 22.21. Over the past 10 years, this metric has ranged from a low of 11.35 to a high of 28.16. The Medical Devices & Instruments industry median Operating Margin % is 3.40. ICARES Medicus' value of 7.48% is 120% above this industry median. Based on the distribution chart, ICARES Medicus ranks #251 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, ICARES Medicus has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ICARES Medicus' Operating Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, ICARES Medicus ranks #251 out of 816 companies for Operating Margin %. This puts ICARES Medicus in the upper half of its industry. The industry median Operating Margin % is 3.40. ICARES Medicus' value of 7.48% is 120% above this benchmark. Historically, ICARES Medicus' own Operating Margin % has ranged from 11.35 to 28.16 over the past decade. While the company's 10-year median is 22.21 vs. the industry median of 3.40, ICARES Medicus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.40, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICARES Medicus's current Operating Margin % of 7.48% is 120% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on ICARES Medicus and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICARES Medicus's current Operating Margin % is 7.48%, which is 66% below median its own 10-year median of 22.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICARES Medicus stock overvalued right now?
Based on GuruFocus' analysis, ICARES Medicus (ROCO:6612) is currently considered Possible Value Trap. The stock's GF Value™ is NT$188.59, compared to a current price of NT$71.60 — trading 62% below its estimated fair value. The current Operating Margin % is 7.48%, which is 66% below median its 10-year median of 22.21 and 120% above the Medical Devices & Instruments industry median of 3.40. ICARES Medicus' overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For ICARES Medicus (ROCO:6612), the current Operating Margin % is 7.48% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICARES Medicus (ROCO:6612) Overvalued in 2026?
Based on GuruFocus' analysis, ICARES Medicus stock appears to be undervalued.
The current stock price of NT$71.60 is trading 62% below its estimated GF Value™ of NT$188.59.
GuruFocus considers ICARES Medicus to be Possible Value Trap.
Key valuation signals for ROCO:6612:
Operating Margin %: 7.48% (66% below median its 10-year median of 22.21)
GF Value™: NT$188.59 vs. price of NT$71.60 (62% below fair value)
Industry Position: 120% above the Medical Devices & Instruments median (#251 of 816)
No single metric tells the full story. See the ROCO:6612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices. In addition, it also designs, develops, manufactures, and sells intraocular lenses and nanomedical devices. The company's operating segments are Europe and America, which derive maximum revenue, China, and R.O.C. Geographically, it generates maximum revenue from the United States, followed by Taiwan, Spain, England, Japan, China, Germany, and other countries.
84GF Score
Get the complete analysis for ROCO:6612
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6612 has been successfully added to your 
